GenoPalate Raises $5.6M
Summary
MILWAUKEE, WI, GenoPalate has closed on $5.6 million in investments in the initial phase of its current $10.6 million round of equity financing. GenoPalate, a nutritional genomics company, has closed on $5.6 million in investments in the initial phase of its current $10.6 million round of equity financing. The funds will be used to grow and enhance GenoPalates product offerings to further assist customers with their personal nutrition needs. GenoPalate is a science-based nutritional genomics company that is paving the way in personalized nutrition by offering revolutionary at-home DNA tests, one-on-one online nutrition programs led by registered dietitians, and personalized supplements. Backed by evidence-based nutrigenomics research and DNA testing, GenoPalate empowers people to reach their optimal health through personalized nutrition.